Broad protection against influenza infection by vectored immunoprophylaxis in mice

Nature Biotechnology

Volumn 31, Issue 7, 2013, Pages 647-652

  Balazs, Alejandro B ^a   Bloom, Jesse D ^b   Hong, Christin M ^a   Rao, Dinesh S ^c   Baltimore, David ^a  

^a CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

^b USA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO-ASSOCIATED VIRUS; INFLUENZA VIRUS; LUNG INFLAMMATION; NEUTRALIZING ANTIBODIES; PATIENT POPULATION; WEIGHT LOSS;

MONOCLONAL ANTIBODIES; VIRUSES;

MAMMALS;

INFLUENZA VIRUS ANTIBODY; NEUTRALIZING ANTIBODY; PARVOVIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADENO ASSOCIATED VIRUS; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENETIC IMMUNIZATION; HUMORAL IMMUNITY; IMMUNOPROPHYLAXIS; INFLUENZA A (H1N1); MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS IMMUNITY; VIRUS NEUTRALIZATION; VIRUS STRAIN; WEIGHT REDUCTION;

ANIMALS; ANTIBODIES, NEUTRALIZING; DEPENDOVIRUS; EPITOPES; GENETIC VECTORS; HUMANS; IMMUNIZATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE;

EID: 84880296945     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2618     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention (CDC). Estimates of deaths associated with seasonal influenza - United States, 1976-2007. MMWR Morb. Mortal. Wkly. Rep. 59, 1057-1062 (2010).
2. Nair, H. et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 378, 1917-1930 (2011).
3. Smith, D.J. et al. Mapping the antigenic and genetic evolution of influenza virus. Science 305, 371-376 (2004).
4. Morens, D.M. & Taubenberger, J.K. Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine. Influenza Other Respir. Viruses 4, 327-337 (2010).
5. Johnson, N.P.A.S. & Mueller, J. Updating the accounts: global mortality of the 1918-1920 'Spanish' influenza pandemic. Bull. Hist. Med. 76, 105-115 (2002).
6. Aspinall, R., Del Giudice, G., Effros, R.B., Grubeck-Loebenstein, B. & Sambhara, S. Challenges for vaccination in the elderly. Immun. Ageing 4, 9 (2007).
7. Goodwin, K., Viboud, C. & Simonsen, L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24, 1159-1169 (2006).
8. Sui, J. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265-273 (2009).
9. Ekiert, D.C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246-251 (2009).
10. Throsby, M. et al. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells. PLoS ONE 3, e3942 (2008).
11. Wei, C.-J. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 329, 1060-1064 (2010).
12. Steel, J. et al. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. mBio 1, e00018-10 (2010).
13. Clark, T.W. et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N. Engl. J. Med. 361, 2424-2435 (2009).
14. Balazs, A.B. et al. Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature 481, 81-84 (2011).
15. Johnson, P.R. et al. Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys. Nat. Med. 15, 901-906 (2009).
16. Bloom, J.D., Gong, L.I. & Baltimore, D. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328, 1272-1275 (2010).
17. Hancock, K. et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361, 1945-1952 (2009).
18. Shultz, L.D. et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174, 6477-6489 (2005).
19. Enserink, M. Infectious diseases. Controversial studies give a deadly flu virus wings. Science 334, 1192-1193 (2011).
20. Collin, N. & de Radiguès, X. World Health Organization H1N1 Vaccine Task Force Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza. Vaccine 27, 5184-5186 (2009).
21. Li, Y. et al. Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009. J. Virol. 84, 8389-8397 (2010).
22. Croyle, M.A., Cheng, X. & Wilson, J.M. Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Ther. 8, 1281-1290 (2001).
23. Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850-856 (2011).
24. Marsh, G.A., Hatami, R. & Palese, P. Specific residues of the influenza A virus hemagglutinin viral RNA are important for efficient packaging into budding virions. J. Virol. 81, 9727-9736 (2007).
25. Krause, J.C. et al. A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J. Virol. 85, 10905-10908 (2011).
26. Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343-1348 (2012).
27. Anonymous. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm. Rep. 42, 1-18 (1993).
28. Nathwani, A.C. et al. Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N. Engl. J. Med. 365, 2357-2365 (2011).
29. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R.G.A. DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97, 6108-6113 (2000).
30. Matrosovich, M., Matrosovich, T., Garten, W. & Klenk, H.-D. New low-viscosity overlay medium for viral plaque assays. Virol. J. 3, 63 (2006).